Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry

UDC.coleccionInvestigaciónes_ES
UDC.endPage1358es_ES
UDC.grupoInvInsuficiencia Cardíaca Avanzada e Transplante Cardíaco (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.issue13es_ES
UDC.journalTitleEuropean Journal of Preventive Cardiologyes_ES
UDC.startPage1346es_ES
UDC.volume30es_ES
dc.contributor.authorChioncel, Ovidiu
dc.contributor.authorBenson, Lina
dc.contributor.authorCrespo-Leiro, María Generosa
dc.contributor.authorAnker, Stefan
dc.contributor.authorCoats, Andrew J.S.
dc.contributor.authorFilippatos, Gerasimos
dc.contributor.authorMcDonagh, Theresa
dc.contributor.authorMargineanu, Cornelia
dc.contributor.authorMebazaa, Alexandre
dc.contributor.authorMetra, Marco
dc.contributor.authorPiepoli, Massimo
dc.contributor.authorAdamo, Marianna
dc.contributor.authorRosano, Giuseppe
dc.contributor.authorRuschitzka, Frank
dc.contributor.authorSavarese, Gianluigi
dc.contributor.authorSeferovic, Petar M.
dc.contributor.authorVolterrani, Maurizio
dc.contributor.authorFerrari, Roberto
dc.contributor.authorMaggioni, Aldo P.
dc.contributor.authorLund, Lars H.
dc.date.accessioned2024-10-18T07:42:54Z
dc.date.available2024-10-18T07:42:54Z
dc.date.issued2023-05-13
dc.description.abstract[Abstract] Aims: To evaluate the prevalence and associations of non-cardiac comorbidities (NCCs) with in-hospital and post-discharge outcomes in acute heart failure (AHF) across the ejection fraction (EF) spectrum. Methods and results: The 9326 AHF patients from European Society of Cardiology (ESC)-Heart Failure Association (HFA)-EURObservational Research Programme Heart Failure Long-Term Registry had complete information for the following 12 NCCs: anaemia, chronic obstructive pulmonary disease (COPD), diabetes, depression, hepatic dysfunction, renal dysfunction, malignancy, Parkinson's disease, peripheral vascular disease (PVD), rheumatoid arthritis, sleep apnoea, and stroke/transient ischaemic attack (TIA). Patients were classified by number of NCCs (0, 1, 2, 3, and ≥4). Of the AHF patients, 20.5% had no NCC, 28.5% had 1 NCC, 23.1% had 2 NCC, 15.4% had 3 NCC, and 12.5% had ≥4 NCC. In-hospital and post-discharge mortality increased with number of NCCs from 3.0% and 18.5% for 1 NCC to 12.5% and 36% for ≥4 NCCs.Anaemia, COPD, PVD, sleep apnoea, rheumatoid arthritis, stroke/TIA, Parkinson, and depression were more prevalent in HF with preserved EF (HFpEF). The hazard ratio (95% confidence interval) for post-discharge death for each NCC was for anaemia 1.6 (1.4-1.8), diabetes 1.2 (1.1-1.4), kidney dysfunction 1.7 (1.5-1.9), COPD 1.4 (1.2-1.5), PVD 1.2 (1.1-1.4), stroke/TIA 1.3 (1.1-1.5), depression 1.2 (1.0-1.5), hepatic dysfunction 2.1 (1.8-2.5), malignancy 1.5 (1.2-1.8), sleep apnoea 1.2 (0.9-1.7), rheumatoid arthritis 1.5 (1.1-2.1), and Parkinson 1.4 (0.9-2.1). Anaemia, kidney dysfunction, COPD, and diabetes were associated with post-discharge mortality in all EF categories, PVD, stroke/TIA, and depression only in HF with reduced EF, and sleep apnoea and malignancy only in HFpEF. Conclusion: Multiple NCCs conferred poor in-hospital and post-discharge outcomes. Ejection fraction categories had different prevalence and risk profile associated with individual NCCs.es_ES
dc.description.sponsorshipSince the start of EORP, the following companies have supported the programme: Abbott Vascular Int. (2011–2021), Amgen Cardiovascular (2009–2018), AstraZeneca (2014–2021), Bayer AG (2009–2018), Boehringer Ingelheim (2009–2019), Boston Scientific (2009–2012), The Bristol Myers Squibb and Pfizer Alliance (2011–2019), Daiichi Sankyo Europe GmbH (2011–2020), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2014–2017), Edwards (2016–2019), Gedeon Richter Plc. (2014–2016), Menarini Int. Op. (2009–2012), MSD-Merck & Co. (2011–2014), Novartis Pharma AG (2014–2020), ResMed (2014–2016), Sanofi (2009–2011), Servier (2009–2021), and Vifor (2019–2022).es_ES
dc.identifier.citationChioncel O, Benson L, Crespo-Leiro MG, Anker SD, Coats AJS, Filippatos G, McDonagh T, Margineanu C, Mebazaa A, Metra M, Piepoli MF, Adamo M, Rosano GMC, Ruschitzka F, Savarese G, Seferovic P, Volterrani M, Ferrari R, Maggioni AP, Lund LH. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry. Eur J Prev Cardiol. 2023 Sep 20;30(13):1346-1358.es_ES
dc.identifier.doi10.1093/eurjpc/zwad151
dc.identifier.issn2047-4873
dc.identifier.urihttp://hdl.handle.net/2183/39677
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.relation.urihttps://doi.org/10.1093/eurjpc/zwad151es_ES
dc.rightsThis is a pre-copyedited, author-produced version of an article accepted for publication in Europena Journal of Preventive Cardiology following peer review. The version of record is available online at Oxford Academic webpage.es_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectAcute heart failurees_ES
dc.subjectComorbiditieses_ES
dc.subjectPrognosises_ES
dc.titleComprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registryes_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublication36d178fd-10a0-48a2-925d-71d185a50eda
relation.isAuthorOfPublication.latestForDiscovery36d178fd-10a0-48a2-925d-71d185a50eda

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Chioncel_Comprehensive_2023.pdf
Size:
3.07 MB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Chioncel_Comprehensive_2023_Suppl.zip
Size:
1.24 MB
Format:
Unknown data format
Description:
Supplementary data